Form 4 holding
Director
CytoMed Therapeutics Ltd
- Security class
- Ordinary Shares, no par value per share
- Shares / value
- 2,469
- Estimated value
- $2,320
- Report date
- 18 Mar 2026
- Price
- $0.9400
- Ownership
- Direct
Chak Hua Yew - Director at CytoMed Therapeutics Ltd
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- GDTC on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Chak Hua Yew since 09 Aug 2025
Reported holdings for Chak Hua Yew in CytoMed Therapeutics Ltd
Transaction history for Chak Hua Yew in CytoMed Therapeutics Ltd
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.